Investors in Twist Bioscience Corp (Symbol: TWST) saw new options become available this week, for the July 2025 expiration. One of the key inputs that goes into the price an option buyer is ...

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference. SOUTH SAN FRANCISCO, Calif., May 15, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and ...

After losing some value lately, a hammer chart pattern has been formed for Twist Bioscience (TWST), indicating that the stock has found support. This, combined with an upward trend in earnings ...

Twist Bioscience (TWST) shares soared 9.9% in the last trading session to close at $47.94. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

TWST's valuation multiples now appear more reasonable, making it a compelling buy for new investors, with a long cash runway and potential self-sustainability by 2025-2026.

Twist Bioscience's silicon-based DNA writing platform offers competitive advantages in synthetic DNA, NGS consumables, and antibody discovery. Learn more on TWST stock here.